Skip to main content
. 2010 Oct 19;103(10):1627–1636. doi: 10.1038/sj.bjc.6605959

Figure 6.

Figure 6

Kaplan–Meier survival analysis for KRAS mutation in CRC of the overall population (A) and of stage II patients in particular (B) for both overall and disease-free survival. Significance was calculated using log-rank statistic.